Effect of HIV-1 infection on human DNA yield from saliva
- PMID: 19723616
- PMCID: PMC2761620
- DOI: 10.1310/hct1004-282
Effect of HIV-1 infection on human DNA yield from saliva
Abstract
Purpose: Saliva is a good source of DNA for genomic research, and leukocytes are a predominant source of DNA in human saliva. Advanced human immunodeficiency virus (HIV)-type 1 infection disrupts tonsillar architecture and depletes tonsillar lymphocytes. We tested whether HIV-1 infection reduces extracted human DNA yield from saliva.
Methods: Approximately 2 mL of expectorated saliva was collected from HIV-infected adults during routine primary care clinic visits and from healthy, HIV-negative controls. Human DNA was manually extracted and was specifically quantified by assaying for the RNAse P gene.
Results: Seventy-five individuals were studied, including 25 HIV-infected adults with <200 CD4+ T cells/mm(3) (i.e., acquired immunodeficiency syndrome), 25 with >200 CD4+ T cells/mm3, and 25 HIV-negative controls. Overall DNA yield was 64.7 microg [29.0-139.7 microg] (median [interquartile range]). Yields were comparable among HIV-infected individuals with lower CD4+ T cell counts (74.3 microg [39.4-151.4 microg]), higher CD4+ T cell counts (63.9 microg [29.2-172.1 microg]), and HIV-negative controls (61.4 microg [28.4-123.4 microg]) (p > .05).
Conclusion: Infection with HIV-1 does not reduce human DNA yield from saliva. Expectorated saliva should provide sufficient extracted native DNA for genomic studies in HIV-infected individuals.
Conflict of interest statement
David W. Haas has received research grants from Bavarian Nordic, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Merck, Tanox, and Tibotec. He is on scientific advisory boards for Glaxo Smith Kline and Tibotec. Rebecca Basham, Danielle Richardson and Cara Sutcliffe have no conflicts.
Figures

References
-
- Centers for Disease Control and Prevention. HIV/AIDS Statistics and Surveillance. 2008. [Accessed February 12, 2009]. Available at: http://www.cdc.gov/hiv/topics/surveillance/index.htm.
-
- Report on the Global AIDS Epidemic. United Nations Programme on HIV/AIDS. 2007. [Accessed February 12, 2009]. Available at: http://www.unaids.org/en/
-
- Palella FJJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med. 1998;338:853–860. - PubMed
-
- U.S.Department of State; 2005. [Accessed February 12, 2009]. The President’s Emergency Plan for AIDS Relief: Five-year strategy. Available at: http://www.state.gov/documents/organization/57420.pdf.
-
- World Health Organization. WHO and HIV/AIDS. [Accessed February 12, 2009]. Available at: http://www.who.int/hiv/en/
Publication types
MeSH terms
Substances
Grants and funding
- AI077505/AI/NIAID NIH HHS/United States
- R01 AI077505/AI/NIAID NIH HHS/United States
- P30 AI054999/AI/NIAID NIH HHS/United States
- U01 AI069439/AI/NIAID NIH HHS/United States
- TL1 RR024978/RR/NCRR NIH HHS/United States
- AI069439/AI/NIAID NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- UM1 AI068636/AI/NIAID NIH HHS/United States
- UM1 AI069439/AI/NIAID NIH HHS/United States
- KL2 RR024977/RR/NCRR NIH HHS/United States
- AI068636/AI/NIAID NIH HHS/United States
- AI54999/AI/NIAID NIH HHS/United States
- RR024975/RR/NCRR NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials